Nephrocare Unit Acquires Philippines Dialysis Center Assets for PHP 89.6 Million

1 min read     Updated on 13 May 2026, 05:57 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Nephrocare Health Services Limited disclosed that its step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has acquired dialysis center assets in Orani, Bataan, Philippines for PHP 89,600,000.00 through an Asset Transfer Agreement dated May 12, 2026, with Orani Hemodialysis Center Inc. The transaction, made under Regulation 30 of SEBI LODR, involves no special rights and is not classified as a related party transaction.

powered bylight_fuzz_icon
40150956

*this image is generated using AI for illustrative purposes only.

Nephrocare Health Services Limited has disclosed that its step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement (ATA) dated May 12, 2026, with Orani Hemodialysis Center Inc. for the acquisition of identified assets relating to a dialysis center located at Orani, Bataan, Philippines. The total consideration for the transaction stands at PHP 89,600,000.00 (Eighty-Nine Million Six Hundred Thousand Pesos Only). The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI Master Circular dated January 30, 2026.

Transaction Details

The ATA was executed between Nephrocare Health Care Services, Philippines Inc., acting as the purchaser, and Orani Hemodialysis Center Inc., acting as the seller. The agreement covers the acquisition of dialysis center assets, subject to the terms and conditions stipulated therein. The key details of the transaction, as disclosed to the stock exchanges, are outlined below:

Particulars: Description
Purchaser Nephrocare Health Care Services, Philippines Inc. (step-down wholly-owned subsidiary)
Seller Orani Hemodialysis Center Inc.
Purpose Acquisition of dialysis center assets
Size of Agreement PHP 89,600,000.00 (Eighty-Nine Million Six Hundred Thousand Pesos Only)
Shareholding in Seller Not Applicable
Special Rights Not Applicable
Related Party Transaction No
Share Issuance Details Not Applicable
Loan Agreement Details Not Applicable

Regulatory Disclosures

Nephrocare Health Services confirmed that the seller, Orani Hemodialysis Center Inc., is not related to the promoter, promoter group, or group companies of the company. As a result, the transaction does not constitute a related party transaction. The purchaser, Nephrocare Health Care Services, Philippines Inc., is a step-down wholly-owned subsidiary of Nephrocare Health Services Limited. There are no special rights included in the agreement, such as the right to appoint directors or rights to share subscription. The disclosure has been made available on the company's website at www.nephroplus.com . The filing was signed by Kishore Kathri, Company Secretary & Compliance Officer (ICSI M. No. F9895).

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+0.45%+9.08%+1.00%+23.78%+23.78%+23.78%

How does the acquisition of the Orani, Bataan dialysis center fit into Nephrocare's broader expansion strategy across the Philippines, and are there additional centers targeted for acquisition in the near term?

What impact could this Philippines asset acquisition have on Nephrocare Health Services Limited's consolidated revenue and EBITDA margins in the upcoming fiscal quarters?

Given the growing prevalence of chronic kidney disease in Southeast Asia, how might Nephrocare leverage this foothold in the Philippines to scale operations across other ASEAN markets?

Nephrocare Health Services
View Company Insights
View All News
like17
dislike

Nephrocare Health Services Schedules Q4FY26 Earnings Conference Call for May 20, 2026

1 min read     Updated on 05 May 2026, 10:09 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Nephrocare Health Services has scheduled its Q4FY26 Results Conference Call for May 20, 2026, at 16:00 IST, hosted by ICICI Securities. Senior leadership including the CMD, Co-Founder, Group CEO, and Group CFO will represent the company. The call will cover audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, with discussions limited to publicly available information.

powered bylight_fuzz_icon
39444184

*this image is generated using AI for illustrative purposes only.

Nephrocare Health Services Limited has announced the scheduling of its Q4FY26 Results Conference Call, pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The call is set to take place on Wednesday, May 20, 2026, at 16:00 IST, and will focus on the company's audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The intimation was filed with BSE Limited and the National Stock Exchange of India Limited on May 04, 2026.

Event Details

The conference call will be hosted by ICICI Securities and will feature key members of Nephrocare Health Services' senior leadership. The following table summarises the scheduled event:

Parameter: Details
Event: Q4FY26 Results Conference Call
Date: Wednesday, May 20, 2026
Time: 16:00 IST
Hosted by: ICICI Securities
Regulatory Reference: Regulation 30, SEBI Listing Regulations

Senior Leadership Representing the Company

The following senior officials of Nephrocare Health Services will represent the company during the call:

  • Mr. Vikram Vuppala — Chairman & Managing Director
  • Mr. Kamal Shah — Co-Founder
  • Mr. Rohit Singh — Group Chief Executive Officer
  • Mr. Prashant Goenka — Group Chief Financial Officer

Access Details

Participants may join the call through the following dial-in numbers:

Region: Number
Universal Access (India): +91 22 6280 1144; +91 22 7115 8045
Singapore (Toll Free): 8001012045
Hong Kong (Toll Free): 800964448
UK (Toll Free): 08081011573
USA (Toll Free): 18667462133

Disclosure and Compliance

The company has clarified that all discussions during the call will be based on publicly available information, and no unpublished price sensitive information (UPSI) is intended to be discussed. The disclosure has been made available on the company's official website at www.nephroplus.com . The intimation was signed by Kishore Kathri, Company Secretary & Compliance Officer (ICSI M. No. F9895), on behalf of Nephrocare Health Services Limited.

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+0.45%+9.08%+1.00%+23.78%+23.78%+23.78%

How has Nephrocare Health Services' revenue and EBITDA margin trended over FY26 compared to previous years, and what guidance might management provide for FY27?

Given the inclusion of both standalone and consolidated results, what acquisitions or subsidiary expansions has Nephrocare undertaken that could significantly impact its consolidated financials?

With dialysis services being highly capital-intensive, how is Nephrocare planning to fund its network expansion, and what is its current debt-to-equity position heading into FY27?

Nephrocare Health Services
View Company Insights
View All News
like17
dislike

More News on Nephrocare Health Services

1 Year Returns:+23.78%